TY - JOUR T1 - Pregnancy control in patients with systemic lupus erythematosus/antiphospholipid syndrome. Part 3: Childbirth. Puerperium. Breastfeeding contraception. Newborn JO - Reumatología Clínica (English Edition) T2 - AU - Delgado,Paloma AU - Robles,Ángel AU - Martínez López,Juan Antonio AU - Sáez-Comet,Luis AU - Rodríguez Almaraz,Esther AU - Martínez-Sánchez,Nuria AU - Ugarte,Amaia AU - Vela-Casasempere,Paloma AU - Marco,Beatriz AU - Espinosa,Gerard AU - Galindo,Maria AU - Casellas,Manel AU - Ruiz-Irastorza,Guillermo AU - Martínez-Taboada,Victor AU - Bartha,Jose Luis SN - 21735743 M3 - 10.1016/j.reumae.2019.09.004 DO - 10.1016/j.reumae.2019.09.004 UR - https://reumatologiaclinica.org/en-pregnancy-control-in-patients-with-articulo-S217357432100054X AB - ObjectiveIn order to agree on the fundamental aspects related to the management of pregnancy in patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS), the Spanish Societies of Gynaecology and Obstetrics, Internal Medicine and Rheumatology have set up a working group for the preparation of three consensus documents. MethodsEach of the Scientific Societies involved proposed five representatives based on their experience in the field of pregnancy control in patients with autoimmune diseases. The recommendations were developed following the Delphi methodology. ResultsThis third document contains the recommendations regarding the management of delivery, puerperium and lactation, including medication use during these periods and the care of the newborn. In addition, a section on contraception is included. ConclusionsThese multidisciplinary recommendations are considered decision-making tools for clinicians involved in the care of patients with SLE/APS during pregnancy. ER -